Sheldon Sloan's most recent trade in Spyre Therapeutics Inc. was a trade of 95,500 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Jan. 15, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Spyre Therapeutics Inc. | Sheldon Sloan | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 95,500 | 95,500 | - | - | Stock Option (Right to Buy) | |
| Spyre Therapeutics Inc. | Sheldon Sloan | Chief Medical Officer | 01 Oct 2024 | 400,000 | 400,000 | - | - | Stock Option (Right to Buy) |